Mark Jacobson | Chief Operating Officer |
Herriot Tabuteau | Chief Executive Officer |
Nick Pizzie | Chief Financial Officer |
Lori Englebert | Senior Vice President, Commercial and Business Development |
Cedric O'Gorman | Senior Vice President, Clinical Development & Medical Affairs |
Charles Duncan | Cantor Fitzgerald |
Marc Goodman | SVB Leerink |
Yatin Suneja | Guggenheim Partners |
Joseph Thome | Cowen & Company |
Thomas Lee | Morgan Stanley |
Raghuram Selvaraju | H.C. Wainwright |
Matt Kaplan | Ladenburg |
Myles Minter | William Blair |
Good morning. And welcome to the Axsome Therapeutics Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, today's conference call is being recorded.